|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,100 KRW | -0.47% |
|
+0.24% | -8.10% |
| 20/03 | MYUNGMOON Pharm co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Tranche Update on MYUNGMOON Pharm co.,Ltd's Equity Buyback Plan announced on May 25, 2023. | CI |
MYUNGMOON Pharm co.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 1,636.66 million compared to KRW 1,138.29 million a year ago. Net income was KRW 582.68 million compared to KRW 965.28 million a year ago.
Basic earnings per share from continuing operations was KRW 17 compared to KRW 29 a year ago. Basic earnings per share was KRW 17 compared to KRW 29 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.10% | 51.42M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
MYUNGMOON PHARM CO.,LTD 